Zimmer Biomet

ZBH is the ticker symbol for Zimmer Biomet, a company classified under the Health Care Equipment industry within the broader Health Care sector.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Key metrics include a return on equity of 1.9%, a debt-to-equity ratio of 0.79.

The company reports trailing twelve-month revenue of $2.09B and net income of $238.10M.

FINOTAUR aggregates real-time and fundamental data on ZBH to help traders and investors make informed decisions. Track ZBH in your trading journal alongside other positions for a unified view of your portfolio.